Peripheral Arterial Disease Trial, Recruiting NCT03203239 Sponsor: University of Alabama at Birmingham Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT03203239
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 18 and 85 who have been diagnosed with peripheral artery disease (a condition affecting blood flow in the arteries, usually in the legs).
  • Both men and women of any ethnicity are welcome to participate.
  • Diagnosis of peripheral artery disease is confirmed by a specific blood pressure ratio test (called an Ankle Brachial Index) that shows an abnormal result either at rest or during a walking test on a treadmill.

Who may not be able to join:

  • People younger than 18 or older than 85 years of age.
  • People who are unable to understand the consent process or cannot read or speak English.
  • People who are currently pregnant.
  • People who have a known allergic reaction or sensitivity to a type of contrast agent used in ultrasound imaging (called perflutren).
  • People who have high blood pressure in the lungs (pulmonary hypertension).
  • People who are currently using illicit drugs.
  • People with blood pressure that is currently untreated and reads above 160/95.
  • People who have sickle cell disease.
  • People who have a history of an abnormal opening between the chambers of the heart (intracardiac shunt).
  • People with certain neurological conditions such as spinal stenosis or unspecified pain disorders.
  • People with any other serious medical conditions that are not currently under control (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nicole L Lohr, MD,PHD, Medical College of Wisconsin

Phone: 414-996-3504

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 January 2018
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in blood flow

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov